AMZN
Amazon.com, Inc.
AMZN's fundamentals are mixed: revenue grew 15%, but free cash flow turned negative. Its PE of 22x looks cheaper than it really is, because one-off gains boosted its recent earnings. Analysts expect strong earnings growth.
CATO
The Cato Corporation
There isn't enough reported data to score CATO yet.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
CATO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Strong |
CATO's balance sheet is currently strong, and its revenue, profitability and cash flow are stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
CATO PE Valuation
CATO has no meaningful PE right now: it lost money over the past year.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
CATO Forward outlook
There aren't enough analyst estimates for CATO to show an outlook.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over CATO on earnings quality, reporting a profit while its opponent remains loss making.
CATO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.30 | +$0.70 |
| Q2 2026 | -$0.01 | +$1.33 |
| Q1 2026 | -$0.31 | +$0.66 |
| Q4 2025 | -$0.49 | +$0.90 |
| Q3 2025 | -$1.00 | -$0.10 |
| Q2 2025 | -$1.34 | -$0.49 |
| Q1 2025 | -$0.97 | +$0.20 |
| Q4 2024 | -$1.39 | -$1.23 |
CATO is still losing money, but far less than before: $0.30 per share over the past year, against $2.01 at its worst in early 2021.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over CATO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over CATO on profitability, with a higher operating margin.
CATO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $165.5M | -6.2% |
| Q2 2026 | $171.1M | +0.5% |
| Q1 2026 | $151.7M | -4% |
| Q4 2025 | $155.4M | +6.3% |
| Q3 2025 | $176.5M | +4.7% |
| Q2 2025 | $170.2M | -3.9% |
| Q1 2025 | $157.9M | -9.7% |
| Q4 2024 | $146.2M | -7.6% |
CATO's revenue fell from its 2021 peak and has held roughly level since: $166M last quarter, down 6.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.4% | -3.5 points |
| Q2 2026 | 5.2% | +3.2 points |
| Q1 2026 | -8.9% | +6.3 points |
| Q4 2025 | -5.3% | +4.8 points |
| Q3 2025 | 3.1% | +2.7 points |
| Q2 2025 | 2% | -4.5 points |
| Q1 2025 | -15% | -8 points |
| Q4 2024 | -10% | -3.5 points |
CATO's operating margin was −0.4% last quarter, down 3.5 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
CATO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $13.1M | +26% |
| Q2 2026 | $7M | +145% |
| Q1 2026 | -$5.6M | +$2.3M |
| Q4 2025 | -$12.9M | +$10.9M |
| Q3 2025 | $10.4M | +555% |
| Q2 2025 | $2.8M | +17% |
| Q1 2025 | -$7.8M | +$5.6M |
| Q4 2024 | -$23.8M | -$12.1M |
CATO has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over CATO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
CATO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1% | +182K shares |
| 1 year | +1% | +191K shares |
| 3 years | -2% | -395K shares |
| 5 years | -11% | -2.4M shares |
| Available history | -20% | -4.7M shares |
CATO has 19M diluted shares, up 1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $111,000 |
| Q2 2026 | $311,000 |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $60,000 |
| Q2 2025 | $935,000 |
| Q1 2025 | $1.5M |
| Q4 2024 | $161,000 |
CATO spent $422,000 buying back its own shares over the past year, down 84% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
CATO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -10.1x | Net Cash |
| Q2 2024 | -48.5x | Net Cash |
| Q4 2023 | -5.6x | Net Cash |
| Q3 2023 | -9.2x | Net Cash |
| Q2 2023 | -5.4x | Net Cash |
| Q1 2023 | -1.6x | Net Cash |
| Q4 2022 | -1.6x | Net Cash |
| Q3 2022 | -1.3x | Net Cash |
CATO has more cash than debt.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
CATO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 2.2 | Oversold |
CATO's weekly RSI is 33 (neutral) and its Stochastic is 2 (oversold).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
CATO PE vs Consumer Cyclical Sector
| Metric | CATO | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
CATO has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over CATO on trend strength, trading above more of its moving averages.
CATO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.36 | 3.8% below |
| 20 week MA | $2.77 | 18% below |
| 50 week MA | $2.97 | 24% below |
| 100 week MA | $3.16 | 28% below |
| 200 week MA | $4.98 | 54% below |
CATO is in a downtrend: it's below all five of its weekly moving averages, and 54% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over CATO on returns for 2026, with the stronger performance.
CATO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $17.2 | $8.20 | -52% |
| 2021 | $8.20 | $16.9 | +106% |
| 2022 | $16.9 | $9.18 | -46% |
| 2023 | $9.18 | $7.14 | -22% |
| 2024 | $7.14 | $3.93 | -45% |
| 2025 | $3.93 | $3.08 | -22% |
| 2026 YTD | $3.08 | $2.27 | -26% |
CATO has finished four years in a row lower, and it's down 26% so far in 2026.